Appetite & satiety: Dual GLP-1 + amylin signalling is reported to reduce appetite and increase satiety in trial subjects
While Dihexa is generally considered safe, certain individuals may need to exercise extra caution or avoid it altogether
Healthcare professionals must therefore balance the substantial benefits of GLP-1 therapy against this potential, though uncommon, risk when prescribing these agents
Severe, persistent upper abdominal pain radiating to the back, accompanied by nausea and vomiting, requires immediate medical assessment and discontinuation of the medication
It achieves this by improving the body's ability to use insulin, reducing inflammation, and enhancing cholesterol levels
Higher than normal levels of LIP, can disrupt the balance of redox and consequently promote ferroptosis in cardiomyocytes (Lou et al., 2021)